NCT05768997View on ClinicalTrials.gov

High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia

PHASE3RecruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Anemia
Interventions
DRUG

Ferric Derisomaltose Injection

Ferric derisomaltose/iron isomaltoside (as iron) (0 weeks): 20mg/kg, diluted in 250ml of 0.9% physiological saline and injected intravenously over 30-60 minutes

DRUG

Darbepoetin Alfa Injection

Darbepoietin alfa (0 weeks, 3 weeks, 6 weeks, 9 weeks): 6.75㎍/kg, subcutaneous or intravenous administration

Trial Locations (1)

Unknown

RECRUITING

Hallym University Medical Center, Anyang-si

All Listed Sponsors
lead

Hallym University Medical Center

OTHER